News

Considering the Chase Sapphire Reserve's 150,000-point bonus? Here are 4 easy-to-miss reasons it's a great deal

The Sapphire Reserve is more than just a big bonus. Carefully considering these factors can help you easily determine if it's a good fit for you.

Checking in On Red Hot AI Infrastructure Stocks

MU, SNDK, VRT

The AI infrastructure stocks have been the story of 2026, delivering massive gains on the back of their bright outlooks thanks to the massive amounts of capital being poured out for the buildout.

GE Gains From Strength in Defense & Propulsion Unit: Can It Sustain?

GE, HWM, RTX

GE Aerospace's Defense & Propulsion unit is gaining from strong military contracts and rising defense demand, supporting continued growth momentum.

PACB & Blank Bio Partner to Advance RNA Foundation Models in Oncology

ISRG, WST, GMED, PACB

PacBio teams with Blank Bio after its $7.2M seed round, using HiFi long reads to build RNA AI models from patient tumor samples.

Reddit Benefits From Solid ARPU Growth: A Sign for More Upside?

SNAP, PINS, RDDT

RDDT's ARPU jumps 44% in the first quarter of 2026 as advertiser growth, AI-driven ad tools, and international expansion boost monetization.

Lowe's Companies Q1 Earnings Call Highlights

LOW

Home Depot Stock Keeps Falling—Analysts Say the Upside Is Still ThereLowe's Companies (NYSE:LOW) reported a modest comparable sales gain in its fiscal first quarter, with executives pointing to stronger spring execution, continued demand from professional customers and growth in

Analog Devices Q2 Earnings Call Highlights

ADI

Analog Devices Provides Much-Needed Pullback: How Low Can It Go?Analog Devices (NASDAQ:ADI) reported record fiscal second-quarter 2026 results, with revenue, profitability and earnings per share exceeding the high end of the company’s prior guidance, executives said on the compan

This stock will be a big winner as Iran disrupts the global energy market. Investors haven't realized it yet

Each day the Strait of Hormuz remains blocked, the likelihood grows that energy prices will remain higher for longer than many are predicting.

Veeva Systems' RTSM Momentum Signals Another Long-Term Growth Driver

CRM, VEEV, IQV

VEEV benefits from RTSM traction with major pharma wins, strengthening its clinical software strategy and long-term R&D growth outlook.

Eli Lilly accuses church bishops, businessmen of fraud in Trulicity drug rebate scheme

Eli Lilly claims in a civil lawsuit that it's the victim of a $200 million plus drug rebate fraud tied to Pentecostal church bishops and businesses.